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Background: Avian influenza virus H9N2 is a panzootic pathogen that affects poultry causing mild to moderate
respiratory distress but has been associated with high morbidity and considerable mortality. Interspecies
transmission of H9N2 from avian species to mammalian hosts does occur. The virus possesses human virus-like
receptor specificity and it can infect humans producing flu-like illness.
Methods: Recently, mild influenza like symptoms were detected in H5N1 vaccinated flocks. Influenza A subtype
H9N2 was isolated from the infected flock. The virus evolution was investigated by sequencing the viral genes to
screen the possible virus recombination. The viral amino acid sequences from the isolated H9N2 strains were
compared to other related sequences from the flu data base that were used to assess the robustness of the
mutation trend. Changes in the species-associated amino acid residues or those that enabled virulence to
mammals were allocated.
Results: Phylogenetic analyses of haemagglutinin and neuraminidase genes showed that the recently isolated
Egyptian strain belonged to the H9N2 sub-lineage that prevails in Israel. The six internal segments of the isolated
virus were found to be derived from the same sub-lineage with no new evidence of reassortment. The results
demonstrated conserved genetic and biological constitution of H9N2 viruses in the Middle East. The recently
isolated H9N2 virus from chicken in Egypt possessed amino acids that could enable the virus to replicate in
mammals and caused severe disease in domestic chickens.
Conclusion: The study highlights the importance of continuous monitoring of the mutations evolved in avian
influenza viruses and its impact on virulence to avian species in addition to its importance in the emergence of
new strains with the capacity to be a pandemic candidate.Background
Influenza A viruses are represented in dozens of anti-
genic subtypes; 17 haemagglutinin (HA) and 10 neur-
aminidase (NA) subtypes [1]. After the transfer of the
influenza viruses from the aquatic birds to a new avian
or mammalian host, the viruses evolve rapidly and cause
mild or occasionally severe respiratory disease [2]. H9N2
viruses have been panzootic in the Middle East and Asia
over the last decade and have been recorded in different
types of poultry worldwide [3]. H9N2 viruses are low
pathogenic avian influenza (LPAI); however, they induce* Correspondence: asa@bsu.edu.eg
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distribution, and reproduction in any mediumsignificant disease in poultry and are occasionally ac-
companied by considerable mortality [4]. They are
represented by two main lineages defined by the proto-
type viruses A/Dk/HK/Y280/97 and A/Qa/HK/G1/97
that circulated in the terrestrial poultry in Asia [5]. A/
Qa/HK/G1/97-like viruses have been involved in the
generation of the highly pathogenic H5N1 virus in 1997
[6]. H9N2 influenza viruses isolated from 1998 to 2010
in Central Asia and the Middle East are clustered in four
distinct groups (A-D). Groups A and B have circulated
extensively in Central Asia and the Middle East, but
groups C and D are restricted to certain countries [7].
H9N2 influenza virus is endemic in poultry all over
Eurasia and has transmitted to mammals [8]. The virus
possesses human virus-like receptor specificity, and it can
infect humans producing flu-like illness [9]. Direct human
infections with avian H9N2 confirm that interspeciesCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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hosts occurs, and it is not uncommon [10]. The disease in
human is usually subclinical [11], and therefore the virus
has the opportunity to circulate and reassort with other
influenza viruses.
Inter-subtype reassortments have been detected be-
tween the co-circulating H9N2 and the highly patho-
genic H5N1 or H7N3 viruses [5,12]. These finding
together with the endemic nature of the H5N1 virus in-
fection in Egypt [13] make the genetic characterization
of other avian viruses circulating in Egypt important for
screening the probable reassortment and/or the dynamic
evolution of new strains with increased virulence to
mammals. The circulation of avian viruses among popu-
lations in different parts of the world increases the gen-
etic diversity of influenza viruses [14]. Reassortment
between the human pandemic strains and an avian virus
of a different subtype is not uncommon [2]. The conse-
quences of the interspecies transmission can be devastat-
ing with all catastrophic consequences.Table 1 Oligonucleotides used for amplification of the eight g

























aPrimer sequences for HA5 were ordered according to information provided by the
Loeffler Institute (FLI), Germany.Here, we describe the isolation of the H9N2 virus from
a broiler- breeder farm in the northern part of Egypt.
The mutation trend and the genetic evolution of the iso-
lated strain were also studied in comparison to other
similar influenza virus serotype; H9N2 in the Middle




The use of animal subjects in this study was approved
by the Ethical Committee of Beni-Suef University.
Clinical data
On 5th May 2011, a six-week-old chicken (broiler-
breeder) flock in the Alexandria Governorate, Egypt suf-
fered from respiratory distress and facial oedema with
low mortality rate (50/10,000). The general health signs
of the flock deteriorated rapidly within 2-3 days to
chronic respiratory disease (CRD). Morbidity reachedenes of the H9N2
ngth Amplicon size (bp) Primer position Reference
20 554 943-962 [16]
20 1496-1515
15 699 392-414 FLIa
20 1167-1189
20 241 937-956 [16]
20 1177-1196
26 247 1126-1151 [17]
30 1372-1343
20 362 548-567 [17]
20 909-890
18 1350 21-38 [13]
20 1346-1365
23 540 1591-1613 [18]
23 2130-2108
21 601 774-793 This study
20 1356-1375
20 456 1678-1697 This study
20 2114-2133
20 665 823-842 [19]
22 1466-1487
22 875 56-77 This study
25 906-930
20 798 23-42 [19]
20 786-805
Laboratory of Molecular and Biological Characterization of AIV, Friedrich
Figure 1 Phylogenetic analysis of the PB1, PB2, PA, HA, NP, NA, M and NS genes of the A/chicken/Egypt/BSU-CU/2011 and selected
H9N2 influenza A virux ses from the GenBank and EMBL databases. The strain isolated in the current study is indicated in red. The selected
viruses were chosen to be representative of the relevant sequences in the GenBank and EMBL databases. The robustness of individual nodes of
the tree was assessed using 1000 bootstrap replicates, and bootstrap values 70% and higher are indicated at key nodes.
Abdel-Moneim et al. Virology Journal 2012, 9:173 Page 3 of 9
http://www.virologyj.com/content/9/1/173
Table 2 Comparison of amino acid signatures in selected genes of avian and human strains to Egyptian H9N2 and H5N1 strains
Gene Residue Aviana Humana H1N1 Pandemic Egyptian H5N1 A/ck/Eg/BSU-CU/11 Egypt. H9N2 2006 b Middle East H9N2 c
2009 1918
PB2 588 A203/T6/V6 I835/V3/A2 T A A32/T1 A A A82/V10/I1
613 V212/A3 T816/I16/A8/V1 V V V33 V V V92/I1
627 E196/K19 K838/R2/E1 E K K32/E1 V E V60/E31/A2
674 A204/S6/T2/G2/E1 T836/A2/I2/P1 A A A33 A A A88/T5
PB1 327 R147/K3 K766/R66 R R R35 R R R81
336 V142/I8 I773/V59 I V V35 V V V81
NP 283 L372/P1 L7/P643 L P L33 L L L78
293 R371/K2 R28/K622 R R R32/K1 R R R78
305 R369/K4 K636/R14 F L R33 R R R78
313 F371/I1/L1 Y642/F8 V Y F33 F F F78
357 Q368/K4/T1 K44/R8/Q1 K K Q33 Q Q Q76/K2
372 E357/D15/K1 D630/E23 E E E33 E E E72/D6
422 R373 K630/R23 R R R33 R R R78
442 T372/A1 A629/T23/R1 T T T33 T T T78
455 D373 E630/D22/T1 D D D32/E1 D D D78
M1 115 V856/I2/L1/G1 I981/V9 V V V35 V V V94
121 T840/A19/P1 A988/T2 T A T35 T T T94
137 T859/A1/P1 A974/T12 T T T35 T T T94
M2 11 T434/I11/S2 I911/T44 T T T35 T T T90/S1
20 S471/N13 N926/S29 S N S35 S S S83N6G1
57 Y481/C1/H1 H913/Y33/R2/Q1 Y Y Y35 Y Y Y87H2
NS2 70 S453/G21/D1 G903/S2 G S S52/G7 S S S83G13
aAvian and human amino acid signatures in different viral genes of influenza A viruses as previously determined [26].
bA/avian/Egypt/920431/2006(H9N2)) is GenBank available data. The strain isolated from live bird market in Egypt (unpublished report).
cAll available H9N2 sequences from the Middle East. The available H9N2 sequences include strains from Emirates, Iran, Israel, Jordan, Lebanon, Saudi Arabia and Tunisia found in the Flu database.
















Table 3 Amino acid site residues associated with virulence in mammals in comparison with Egyptian isolates
Gene Site Virulent Avirulent A/ck/Eg/BSU-CU/11 Egypt H9N2 2006b Middle East H9N2 Egyptian H5N1 isolates Reference
PB2 627 K E V E V60/E31/A2 K [27,28]
701 N D D D D D [29]
PB1 317 I M/V I M M M/V [27,28]
M2 64 S/A/F P S S S S [30]
69 P L P P P P [30]
NS1 42 S A/P S S S S [31]
92 E D D D D D [28]
97/92 E D E E E E [32]
127 N T/D/R/V/A T N N57/T42 T/I [33]
189 N D/G D D D98/N1 D [34]
195 T/Y S S S S S [35]
NS2 31 I M I I I M [34]
56 Y H/L H H H98/Y1 H [34]
aVirulent and non virulent amino acid residues refer to the ability of the virus to replicate in mammals as determined by Lycett et al. [30].
bA/avian/Egypt/920431/2006(H9N2)) is GenBank available data. The strain isolated from live bird market in Egypt (unpublished report).
cAll available H9N2 sequences from the Middle East. The available H9N2 sequences include strains from Emirates, Iran, Israel, Jordan, Lebanon, Saudi Arabia and
Tunisia found in the Flu database.
Numerical superscripts refer to the number of strains that possess those residues.
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to antibiotics. The clinical and post-mortem findings
revealed severe tracheitis, cyanosis of the head and
patches of congestion in the shanks particularly under
the hock joint as well as pericarditis, perihepatitis, peri-
tonitis and air-saculitis. The overall body weights and
feed conversion rate were significantly affected.Sampling and virus isolation
Ten paired tracheal and cloacal swab samples were col-
lected in a sterile phosphate buffer saline during the
general surveillance of influenza viruses in Egypt. Swabs
were routinely processed individually. Infected materials
were pooled, centrifuged at 500 × g for 10 min. and a
gentamicin sulfate solution (50 mg/ml) was added prior
to inoculation into the allantoic cavity of five, 10-
day-old specific pathogen free embryonated chicken
eggs (100 μl/egg). Inoculated embryos were incubated
at 37°C for 24-48 h.Haemagglutination (HA) and Avian influenza virus
antigen detection
The allantoic fluid of pooled infected embryos was sub-
jected to haemagglutination in a 25-μl volume in 96-
well-haemagglutionation-plate as described [15]. HA
positive allantoic fluid was screened for the AIV group
and H5 antigens using the rapid chromatographic strip
test (Animal Genetic Inc. Korea) according to manufac-
turer instructions. Negative and positive controls were
included along with the tested samples.Viral RNA extraction and RT PCR
The extraction of viral RNA was conducted from a virus
containing allantoic fluid using a spin column purifica-
tion kit (Koma Biotech. Inc., Korea). The influenza sub-
type was first screened using H5, H7, H9, N1, N2 and
N3 specific primers (Table 1). Amplification of internal
genes was performed with gene-specific primers for the
six viral genes: PB2, PB1, PA, HA, NP, NA, M and NS
(Table 1) using a Koma one step RT PCR kit (Koma Bio-
tech. Inc., Korea). PCR amplicons were subjected to
electrophoresis in a 1.5% agarose gel. Specific bands of
expected sizes were excised and purified using a QIA-
quick gel extraction kit (Qiagen, Germany). Purified RT-
PCR products were sequenced directly in both forward
and reverse directions (Macrogen, Korea). Different gene
sequences were assembled by trimming primer-linker.
Sequence data of the H9N2 Egyptian strain isolated in
the current study are available in the GenBank database
(Accession No: JQ611701 - JQ611708).
Genetic and phylogenetic analysis
Sequence analysis of the viral genes was conducted using
Mega 4.1 as previously described [20]. Sequence align-
ments were constructed for the partial coding regions of
each of the eight genomic segments. For comparison,
the multisequence and phylogenetic analyses of the iso-
lated H9N2 strain in the current study, the H9N2 virus
strain that was isolated from Egypt on 2006 (All
sequences except HA gene are available), and the re-
cently isolated Egyptian strain from quail [21] as well as
different H9N2 virus lineages circulated in the Middle
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H9 and N2 genes were included. On the other hand, we
screened the possible reassortment in the isolated H9N2
strain in comparison to different H9N2 strains. All gene
sequence data were collected from the National Center
for Biotechnology Information (NCBI) flu database. The
neighbour-joining method with Kimura two-parameter
distances was used for constructing the phylogenetic
trees using the Mega 4.1 [22]. The reliability of the in-
ternal branches was assessed by the p-distance substitu-
tion model and 1000 bootstrap replications.
Deduced amino acid sequence analysis
The multisequence alignment tool available in the flu
database was used to compare the deduced amino acid
sequences of the six internal genes of the Egyptian
H9N2 strain with other H9N2 strains from the Middle
East, and Egyptian H5N1 isolates available in the flu
database as well as the H1N1 2009 pandemic strain in
order to screen amino acid signature and mutation trend
change. Amino acid residues that have associated with
mammalian virulence were also screened.
Results and discussion
In the current study, we described the isolation of H9N2
from chicken flocks suffering from respiratory distress
with morbidity reached 70% and mortality reached 15%.
The virus was isolated from the Northern part of Egypt;
the Alexandria Governorate. The suspected materials
from the infected birds induced embryo death after 48 h
of inoculation. The infective allantoic fluid was able to ag-
glutinate chicken red blood cells and reacted positive with
the AIV group but not H5 antigens using the rapid chroma-
tographic strip test. It also reacted negatively upon testing
with RT-PCR using H7, H5, N1, N3 specific primers (data
not shown). Positive results were obtained upon testing
with RT-PCR using H9 and N2 specific oligonucleotides.Table 4 Comparison of the deduced amino acid sequence of
influenza A viruses
M2 Residue Aviana Humana 2009 H1N1 Pandemic strain Egyptian
10 P P P P
11 T I T T
13 N N S N
14 G E E E
16 E G E E
18 K R R R
20 S N S S
aAvian and human amino acid residues allocated by de Filette et al. [38].
bA/avian/Egypt/920431/2006(H9N2)) is GenBank available data. The strain isolated f
cAll available H9N2 sequences from the Middle East. The available H9N2 sequences
Tunisia found in the Flu database.
Numerical superscripts refer to the number of strains that possess those residues.Blast analysis of the nucleotide sequences from the eight
viral genes showed that the recently isolated Egyptian
H9N2 strain, A/chicken/Egypt/BSU-CU/2011, was closely
related to the other Middle East H9N2 strains. The virus
shared the common ancestor A/Qa/HK/G1/97 isolate
which has contributed the internal genes of the H5N1 virus
circulating in Asia. The NA gene of A/chicken/Egypt/
BSU-CU/2011 is closely related to the newly isolated
Egyptian quail strain [21] (Figure 1), both were iso-
lated on May 2011 in a consequent manner: 5th May
and 28th May 2011 for chicken and quail isolates re-
spectively. Meanwhile, it seems that the H9N2 circu-
lated in Egypt in undetectable manner as we recorded
a serological evidence of H9 spread throughout Egypt
on 2009-2010 [23]. We could not align the HA of the
isolated chicken strain in the current study with the Egyp-
tian quail strain due to the difference in the amplicon sites
on the target gene, however, both were found closely
related to the Israeli strains (2007-2009).
The evolutionary trees of the PB2, PB1, PA, HA, NP,
NA, M and NS genes revealed that the alleles
corresponding to the viral segments of the A/chicken/
Egypt/BSU-CU/2011 isolate were all Eurasian in origin
(Figure 1). The phylogenetic analysis suggested that all
the eight alleles of the A/Egypt/chicken/BSU-CU/2011
were closely related to Israeli isolates (2007-2009) with
an average percent pairwise nucleotide distances less
than <5%. Accordingly, they possess the same subtype of
Israeli isolates based on the genome constellations of the
H9N2 viruses described by Fusaro et al. [7]. On the
other hand, the PB2, HA, NA, M alleles of the A/chicken/
Egypt/BSU-CU/2011 are derived from the G1 lineage,
while the PB1, PA, NP, NS are not related probably due to
the inter-subtype reassortment (Figure 1). According to
Fusaro et al. typing of H9N2 strains circulated in the Cen-
tral Asia and the Middle East, the PB2, PB1, PA and NP
gene segment constellation of A/chicken/Egypt/BSU-CU/M2 of the A/chicken/Egypt/BSU-CU/2011 with other








rom live bird market in Egypt (unpublished report).
include strains from Emirates, Iran, Israel, Jordan, Lebanon, Saudi Arabia and
Table 5 Amino acid residues of the H9N2 viruses that correlate with replication in mammals in comparison to
A/chicken/Egypt/BSU-CU/2011 residues
Gene Residue No. Non Virulenta Virulenta A/ck/Eg/BSU-CU/11 Egypt H9N2 2006b Middle East H9N2c
PA 672 F L L L L
NP 398 K Q Q Q Q
M1 195 A S S S S
M2 14 E G E G E30A3G59
NS1 25 R Q Q Q Q
225 A T T T A1LR1rT69
NS2 14 T M/I/K M M K4M31L5V2Q2
aVirulent and non virulent amino acid residues refer to the ability of the virus to replicate in mice as determined by Li et al. [51].
bA/avian/Egypt/920431/2006(H9N2)) is GenBank available data. The strain isolated from live bird market in Egypt (unpublished report).
cAll available H9N2 sequences from the Middle East. The available H9N2 sequences include strains from Emirates, Iran, Israel, Jordan, Lebanon, Saudi Arabia and
Tunisia found in the Flu database.
Numerical superscripts refer to the number of strains that possess those residues.
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NA, M and NS are related to group B segment constella-
tion [7].
Understanding the genetic characteristics and mutation
trend of the H9N2 virus isolated in Egypt provides clues
to understand the ecology of H9N2. The haemagglutinin
cleavage motif sequence of the A/Chicken/Egypt/BSU-
CU/2011 was found to be PARSSR/GLF; thus, confirm-
ing the low pathogenic nature of the Egyptian H9N2
strain however, it was similar to the RX-RYK-R [24]. This
genetic constitution suggested that the current H9N2
strain may have the potential to acquire basic amino
acids in the HA connecting the peptide sequence needed
to become highly pathogenic. The virus neuraminidase
showed high homology to the Egyptian quail strain and
differed only in a single amino acid substitution (data not
shown) and both found closely related to Israeli H9N2
2008 strains (Figure 1).
The PB2 protein of the A/Chicken/Egypt/BSU-CU/
2011 displayed valine (V) at position 627 (Tables 2 and 3),
two avian like amino acids at positions 661 alanine (A)
(data not shown) and lysine (K) (Table 3) found in the
functional domain that is responsible for the interaction
with other polymerase components [25].
Amino acid substitutions at one of the M2 residues;
26, 27, 30, 31, 34, or 38 could lead to amantadine resist-
ance [36,37]. None of such amino acid substitutions
were found in the Egyptian strain (data not shown). De
Filette et al., delineated M2 specific sequences specific
for human, swine and avian species [38]. In comparison
to the current Egyptian isolate, it was noted that it pos-
sessed three human specific residues; E14, G16 and R18
[38,39]. Interestingly, asparagine (N13) to a serine (S)
substitution was detected in the M2 of both the Egyptian
strain (Table 4) and the pandemic H1N1 strains [40].
Many studies have reported that the NS1 protein sup-
pressed the host antiviral defenses at multiple levels and
were correlated to virulence [31,41]. Sequence analysisof the non structural protein gene (NS1) of the Egyptian
strain showed that it did not have the five amino acid
(TIASV) deletions and contained the "KSEV" PDZ ligand
(PL) C-terminal motif. It is apt to mention that increas-
ing the length of the 2009 H1N1 NS1 protein to 230 aa
did not increase the virus replication in human and pig
cells [42]; however, NS1 with 5 amino acid deletion resi-
dues showed increased virulence in both mouse and
poultry [32]. Another study reported that NS1 with
truncations were found to stimulate more interferon
than viruses with full- length NS1 proteins and were
consequently more attenuated in mice [43]. The Egyp-
tian strain: A/chicken/Egypt/BSU-CU/2011, possessed
PDZ ligand C-terminal KSEV domain (data not shown).
The C-terminal domain of NS1 functions as a species-
specific virulence domain. Most of the avian influenza
viruses possess an NS1 protein with a PDZ ligand C-
terminal ESEV domain whereas human viruses have a
conserved RSKV domain. NS1 proteins with C-terminal
ESEV, KSEV, and EPEV domains were shown to bind to
PDZ domains containing cellular proteins [44]. Viruses
that possess RSKV motif, which lacks a PDZ- binding
domain, replicated more efficiently than those harbour-
ing ESEV in human and duck cells [45]. This finding
suggested that the ability of NS1 to interact with PDZ-
contained proteins did not contribute to the virulence
[46]. Nevertheless, insertion of four C-terminal aa, either
ESEV, KSEV, or EPEV, into avirulent viruses resulted in
an increase in virus virulence [46]. The RNA-binding
domain of the Egyptian H9N2 displayed amino acid resi-
dues proline (P31), asparagine (D34), arginine (R35),
(R38), lysine (K41), glycine (G45), arginine (R46) and
threonine (T49). R38 and K41, which were found to be
critical for RNA binding as well amino acid residues
P31, D34, R35, G45, R46, T49 and D55, also mediated
NS1-dsRNA interaction [47]. Amino acid substitutions:
alanine (A) or proline(P) to serine (S) at position 42 and
asparagine (D) to glutamic acid (E) at positions 97 were
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were among those responsible for the virulence of H5N1
in mammalian species and cytokine resistance [48]. In
addition, amino acid substitutions: leucine (L) to phenyl-
alanine (F) at position 103 and isoleucine (I) to methio-
nine (M) at position 106 were found to be adaptive
genetic determinants for growth, and virulence in both
mammals and avian NS1 genes [49]; interestingly, the
Egyptian strain harboured both of these amino substitu-
tions. The Egyptian strain also harboured glycine (G184)
in addition to its contribution to cleavage and polyade-
nylation specificity factor binding; G184 strongly affected
the viral virulence by an unknown mechanism [50].
Among the Middle East H9N2 available strains, the
A/chicken/Egypt/BSU-CU/2011 showed unique amino
acid changes at leucine (L98) and threonine (T180) of
the NS1 protein.
In addition we have compared the amino acid residues
associated with H5N1 virulence in mammals [27-35] to
its corresponding residues in the A/chicken/Egypt/BSU-
CU/2011 as well as the Middle Eastern H9N2 strains.
The A/chicken/Egypt/BSU-CU/2011 possessed virulent
amino acid substitutions in: PB1, M317 to I; NS1, A41
to S, E97 to D; NS2, M31 to I; M2, P64 to S and L69 to
P. All the detected virulent residues are also found in
the H9N2 strains from the Middle East and Egyptian
H5N1 strains. Interestingly, H9N2 in the current study
possessed the virulent residue I317 in the PB1 protein
(Table 3); this virulent residue has never been seen in
the Egyptian H5N1 isolates.
Chen et al., delineated avian and human amino acid
signatures in different viral genes of influenza A viruses
[26]. In the current study we have compared some of
such amino acid signatures to the A/chicken/Egypt/
BSU-CU/2011, H9N2 strains in the Middle East, H1N1
strains from 1918 and 2009 pandemics as well as the
Egyptian H5N1 strains that were available in the Gen-
Bank for the five internal genes (PB2, PB1, NP, M and
NS). We have found that the amino acid signatures in
the A/chicken/Egypt/BSU-CU/2011 and H9N2 viruses
circulated in the Middle East and most of the Egyptian
H5N1 have possessed avian like amino acid signatures
(Table 2). G9 and G1 like viruses as well as H9N2
viruses that were isolated in Hong Kong in 2003 were
found to have the ability to replicate systemically and
are lethal for mice [3]. Most of the viruses that contain
G1-like genes were able to replicate in the mouse lungs
without prior adaptation [51]. Meanwhile, Li et al.,
determined amino acid substitutions associated with the
virulence of H9N2 viruses to mice [51]: PA F672 to L;
NP, K398 to Q; M1, A195 to S; NS1, R25 to Q, A225 to
T, and NS2, T14 to M substitutions were detected in the
A/chicken/Egypt/BSU-CU/2011 and the Middle East
H9N2 strains (Table 5).Conclusion
The genetic characteristics and mutation trend of the
H9N2 virus isolated from chicken in Egypt was
described. The increased mortality that associated with
the disease described here, might dente additional factors
that affected the case severity and allowed the LPAI-
H9N2 virus to cause severe signs like. The study provided
evidences to further understand the mutation trend rele-
vant to inter-species transmission of H9N2 influenza A
viruses. Genetic characterization of influenza viruses cir-
culating in Egypt is critically important to provide insight
into the key features for emergence of H9N2 among
poultry and as a potential pandemic virus.
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